Methods | Eight-week double-blind, randomised study. | |
Participants | Outpatients with a diagnosis of depressive episode less than 2 months duration, according to DSM-III criteria, with a minimum score of 25 on the MADRS. Age range: 18-65 yeras old. Exclusion criteria: absence of resistance to mianserin or fluoxetine, absence of associated psychotropic treatment, with the exception of prazepam (40 mg/day) |
|
Interventions | Fluoxetine: 33 participants. Mianserin: 32 participants. Fluoxetine dose range: 20-40 mg/day. Mianserin dose range: 60-90 mg/day. |
|
Outcomes | Hamilton Rating Scale for Depression, Hamilton Rating Scale for Anxiety, Montgomery and Asberg Scale for Depression (MADRS) | |
Notes | Funding: by industry | |
Risk of bias | ||
Item | Authors’ judgement | Description |
Allocation concealment? | Unclear | B - Unclear |